Brookfield Business Corp

Asset in Stage 3 distribution with bearish medium-term structure: price below declining moving averages, active support failure and lower highs/lower lows patterns confirm distribution. Long-term uptrend intact but overshadowed by near-term weakness. No mean-reversion edge available. Execution should await rallies into short-term EMAs or the 50-day SMA and subsequent rejection for structurally appropriate sell opportunities.

• ↑Multiplex sale generates ~$530M cash, bolstering liquidity
• ↑Q4 2025 revenue surged 221% YoY to $7.1B
• ↓Negative earnings yield implies overvaluation risk